IPO Listed — 13 Feb 2026
Listing Price: ₹111
Biopol Chemicals SME IPO GMP History | Listing Price ₹111 & Kostak Rate
Biopol Chemicals SME IPO has been listed on February 13, 2026 at a listing price of ₹111, against the issue price of ₹108 — a gain of ₹3 (+2.78%). The GMP peaked at ₹3 on 13 February 2026 and reached a low of ₹0 on 9 February 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Biopol Chemicals SME IPO raised ₹31 Cr. Cr. through its IPO at a price band of ₹102 to ₹108 per share, with a lot size of 1200 shares. The IPO was open for subscription from 06 Feb 2026 to 10 Feb 2026.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 13 Feb 2026 | ₹ 3 | 3% | ₹ 0 | ₹ 2700 | |
| 12 Feb 2026 | ₹ 3 | 3% | ₹ 0 | ₹ 2700 | |
| 11 Feb 2026 | ₹ 3 | 3% | ₹ 0 | ₹ 2700 | |
| 10 Feb 2026 | ₹ 3 | 3% | ₹ 0 | ₹ 0 | |
| 09 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 07 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 06 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 05 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 04 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 03 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 02 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 01 Feb 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 31 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 30 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 29 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 28 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 | |
| 27 Jan 2026 | ₹ 0 | -- | ₹ 0 | ₹ 0 |
Biopol Chemicals SME IPO Dates
| Event | Date |
|---|---|
| Open Date | 06 Feb, 2026 |
| Close Date | 10 Feb, 2026 |
| Allotment Date | 11 Feb, 2026 |
| Refund Date | 12 Feb, 2026 |
| Credit to Demat | 12 Feb, 2026 |
| Listing Date | 13 Feb, 2026 |
Biopol Chemicals SME IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹108 |
| GMP-Based Estimate (Pre-Listing) | ₹111 (+2.8%) |
| Actual Listing Price | ₹111 (+2.78%) |
| Listing Gain / Loss | +₹3 per share |
| Listing Date | 13 Feb, 2026 |
Is Biopol Chemicals SME IPO GMP Reliable?
Grey market premium for Biopol Chemicals SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Biopol Chemicals SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Biopol Chemicals SME IPO IPO Kostak Rate Explained
The Kostak rate for Biopol Chemicals SME IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was Retail: ₹2700, SHNI: ₹, BHNI: ₹. Unlike Kostak, Subject to Sauda only applies if you receive allotment.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Biopol Chemicals SME IPO
The company’s product portfolio includes bio-based chemicals, polymers, and additives designed to replace conventional synthetic materials. Its business model is centred on research-driven manufacturing and long-term client partnerships, catering to both domestic and international markets. By emphasising sustainability and cost-effective production, Biopol Chemicals aims to strengthen its position in the growing green chemicals segment while maintaining consistent operational efficiency.
Frequently Asked Questions about Biopol Chemicals SME IPO
What is the GMP of Biopol Chemicals SME IPO?
The current Grey Market Premium (GMP) of Biopol Chemicals SME IPO is ₹ 3.
What is the Kostak Price of Biopol Chemicals SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Biopol Chemicals SME IPO is : Retail: ₹ 0, SHNI: ₹ 0, BHNI: ₹ 0.
What is the Subject to Sauda Price of Biopol Chemicals SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is : Retail: ₹ 2700, SHNI: ₹ 0, BHNI: ₹ 0.
What was the actual listing price of Biopol Chemicals SME IPO?
Biopol Chemicals SME IPO listed on February 13, 2026 at ₹111, against the issue price of ₹108 — a gain of +2.78%.
How did the GMP of Biopol Chemicals SME IPO trend before listing?
The GMP of Biopol Chemicals SME IPO was stable in its final days before listing. The GMP peaked at ₹3 on 13 February 2026. View the day-wise table above for the complete GMP history.
Explore Biopol Chemicals SME IPO Further
For a complete picture before making your investment decision, explore these resources:
Discussion 0
No comments yet
Be the first to share your thoughts!